Olaparib Powder

  • Main Ingredient:Olaparib
  • Origin: China
  • Cas number: 763113-22-0
  • Sample:10-20g Available
  • Our Certification: ISO, HACCP, Organic, HALAL, KOSHER, SC
  • Shelf Life: 2 years
  • Delivery Time: 7-15 days
  • Application: Food&beverage
  • OEM&ODM: Powder, capsule, tablet, liquid form
  • Our Packing: 25kg/barrel, 10kg/25kg/Carton, 1kg/5kg/10kg/bag or your request

Product Details

Olaparib powder is a medication used for the treatment of certain types of cancer. It belongs to a class of drugs known as PARP inhibitors and is used to treat patients who have specific genetic mutations, such as BRCA mutations. It works by blocking the action of an enzyme called PARP, which is involved in the repair of damaged DNA.

Olaparib is used to treat ovarian, fallopian tube, or primary peritoneal cancer in women who have already undergone chemotherapy. This drug belongs to a class of medications known as PARP inhibitors. olaparib is made using a precise and sophisticated manufacturing process that ensures purity, quality, and consistency.

This medication has shown promising results in the treatment of ovarian cancer, breast cancer, and prostate cancer, among others. It is given orally in the form of a capsule and is generally well-tolerated by patients.

The use of olaparib represents a significant breakthrough in cancer treatment, providing a new option for patients who may not have responded to other therapies. It has the potential to improve survival rates and quality of life for those who are suffering from cancer.

Health Benefits

  • Treats BRCA-Mutated Cancers

Olaparib is known for its ability to treat cancers that have BRCA mutations. BRCA genes are responsible for suppressing tumor growth and repairing damaged DNA. When there is a mutation in this gene, it can increase the risk of developing certain types of cancer. Olaparib works by inhibiting an enzyme called PARP, which cancer cells with BRCA mutations depend on to repair damaged DNA. This way, Olaparib can help slow down or even stop the progression of these types of cancers.

  • Reduces Recurrence of Ovarian Cancer

Olaparib has also been found to help reduce the recurrence of ovarian cancer. In a clinical trial, women who received Olaparib maintenance therapy after completing standard chemotherapy had a longer progression-free survival time compared to those who did not receive Olaparib. This means that Olaparib can help reduce the chances of ovarian cancer coming back after treatment, increasing the chances of long-term remission.

  • Improves Quality of Life

Olaparib can also improve the quality of life for cancer patients by reducing the need for chemotherapy. Since Olaparib is a targeted therapy, it only affects cancer cells and not healthy cells. This means that patients experience fewer side effects associated with chemotherapy, such as nausea, hair loss, and fatigue. Olaparib also allows patients to continue with their normal daily routines because it does not require extended hospitalization or recovery time.

  • Promotes Personalized Treatment

Another benefit of Olaparib is that it facilitates personalized treatment for cancer patients. With genetic testing, doctors can determine if a patient has BRCA mutations that can be targeted with Olaparib. This way, patients can receive tailored treatment plans that are specific to their needs, ultimately increasing the success of their treatment.

* This statement for educational purposes only. It has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Inquiry